Molina Healthcare (NYSE: MOH) is expected to report Q2 earnings on July 26. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Molina Healthcare's revenues will expand 29.6% and EPS will drop -97.4%.

The average estimate for revenue is $1.51 billion. On the bottom line, the average EPS estimate is $0.01.

Revenue details
Last quarter, Molina Healthcare reported revenue of $1.37 billion. GAAP reported sales were 23% higher than the prior-year quarter's $1.12 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, EPS came in at $0.39. GAAP EPS of $0.39 for Q1 were 2.6% higher than the prior-year quarter's $0.38 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
For the preceding quarter, gross margin was 17.7%, 70 basis points worse than the prior-year quarter. Operating margin was 2.4%, 40 basis points worse than the prior-year quarter. Net margin was 1.3%, 30 basis points worse than the prior-year quarter.

Looking ahead
The full year's average estimate for revenue is $5.98 billion. The average EPS estimate is $0.81.

Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 131 members out of 144 rating the stock outperform, and 13 members rating it underperform. Among 39 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 36 give Molina Healthcare a green thumbs-up, and three give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Molina Healthcare is hold, with an average price target of $36.60.

Over the decades, small-cap stocks, like Molina Healthcare have provided market-beating returns, provided they're value priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: Two Small Caps the Government Won't Let Go Broke." Click here for instant access to this free report.